Brief: Fortress Biotech Announces Reverse Stock Split
09/10/2023 17:51
Oct 9 (Reuters) - Fortress Biotech Inc FBIO.O :
* FORTRESS BIOTECH ANNOUNCES REVERSE STOCK SPLIT
* FORTRESS BIOTECH INC - IT WILL EFFECT A 1-FOR-15 REVERSE
STOCK
SPLIT OF ITS ISSUED AND OUTSTANDING COMMON STOCK
* FORTRESS BIOTECH INC - EXPECTS COMMON STOCK TO BEGIN
TRADING ON
A SPLIT-ADJUSTED BASIS ON NASDAQ AS OF COMMENCEMENT OF TRADING
ON OCTOBER 10, 2023
Source text for Eikon: ID:nGNX2f5WWR
Further company coverage: FBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi